|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 762.00 JPY | +1.87% |
|
-1.04% | +21.53% |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 11.14B | 13.31B | 14.35B | 15.05B | 15.59B | |||||
Total Revenues | 11.14B | 13.31B | 14.35B | 15.05B | 15.59B | |||||
Cost of Goods Sold, Total | 7.06B | 8.04B | 8.4B | 8.92B | 8.94B | |||||
Gross Profit | 4.08B | 5.28B | 5.95B | 6.13B | 6.65B | |||||
Selling General & Admin Expenses, Total | 3.4B | 3.72B | 3.97B | 4.22B | 4.47B | |||||
R&D Expenses | 408M | 450M | 510M | 494M | 474M | |||||
Other Operating Expenses | - | - | - | - | - | |||||
Other Operating Expenses, Total | 3.81B | 4.17B | 4.48B | 4.71B | 4.95B | |||||
Operating Income | 277M | 1.1B | 1.48B | 1.42B | 1.7B | |||||
Interest Expense, Total | -22M | -28M | -47M | -50M | -46M | |||||
Interest And Investment Income | 14M | 19M | 23M | 29M | 31M | |||||
Net Interest Expenses | -8M | -9M | -24M | -21M | -15M | |||||
Income (Loss) On Equity Invest. | 18M | 9M | 11M | 18M | 12M | |||||
Currency Exchange Gains (Loss) | 29M | 32M | 23M | -27M | 40M | |||||
Other Non Operating Income (Expenses) | 153M | 90M | 86M | 51M | 30M | |||||
EBT, Excl. Unusual Items | 469M | 1.23B | 1.57B | 1.44B | 1.77B | |||||
Gain (Loss) On Sale Of Investments | 12M | 4M | - | 6M | - | |||||
Gain (Loss) On Sale Of Assets | 32M | 2M | - | -1M | -1M | |||||
Asset Writedown | -44M | -11M | -9M | -27M | -8M | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | 39M | -203M | -13M | -1M | -1M | |||||
EBT, Incl. Unusual Items | 508M | 1.02B | 1.55B | 1.42B | 1.76B | |||||
Income Tax Expense | 219M | 338M | 416M | 384M | 325M | |||||
Earnings From Continuing Operations | 289M | 681M | 1.13B | 1.04B | 1.44B | |||||
Net Income to Company | 289M | 681M | 1.13B | 1.04B | 1.44B | |||||
Minority Interest | -3M | -32M | -32M | -7M | -36M | |||||
Net Income - (IS) | 286M | 649M | 1.1B | 1.03B | 1.4B | |||||
Net Income to Common Incl Extra Items | 286M | 649M | 1.1B | 1.03B | 1.4B | |||||
Net Income to Common Excl. Extra Items | 286M | 649M | 1.1B | 1.03B | 1.4B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 12.77 | 28.97 | 49.19 | 45.93 | 64.93 | |||||
Basic EPS - Continuing Operations | 12.77 | 28.97 | 49.19 | 45.93 | 64.93 | |||||
Basic Weighted Average Shares Outstanding | 22.4M | 22.4M | 22.4M | 22.4M | 21.56M | |||||
Net EPS - Diluted | 12.77 | 28.97 | 49.19 | 45.93 | 64.93 | |||||
Diluted EPS - Continuing Operations | 12.77 | 28.97 | 49.19 | 45.93 | 64.93 | |||||
Diluted Weighted Average Shares Outstanding | 22.4M | 22.4M | 22.4M | 22.4M | 21.56M | |||||
Normalized Basic EPS | 12.95 | 32.8 | 42.43 | 39.94 | 49.67 | |||||
Normalized Diluted EPS | 12.95 | 32.8 | 42.43 | 39.94 | 49.67 | |||||
Dividend Per Share | 6 | 9 | 14 | 16 | 20 | |||||
Payout Ratio | 46.85 | 24.19 | 24.41 | 30.32 | 29.86 | |||||
Supplemental Items | ||||||||||
EBITDA | 884M | 1.83B | 2.04B | 2.02B | 2.29B | |||||
EBITA | 337M | 1.22B | 1.54B | 1.48B | 1.76B | |||||
EBIT | 277M | 1.1B | 1.48B | 1.42B | 1.7B | |||||
Effective Tax Rate - (Ratio) | 43.11 | 33.17 | 26.84 | 27.04 | 18.46 | |||||
Normalized Net Income | 290M | 735M | 950M | 895M | 1.07B | |||||
Non-Cash Pension Expense | 41.46M | 29.94M | 28.12M | 36.08M | 24.64M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 418M | 457M | 519M | 499M | 479M |
- Stock Market
- Stocks
- 7727 Stock
- Financials OVAL Corporation
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















